Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001104659-25-003873
Filing Date
2025-01-15
Accepted
2025-01-15 21:15:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3145
  Complete submission text file 0001104659-25-003873.txt   4669
Mailing Address MILLENNIUM PHARMACEUTICALS, INC. 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Protopapas Anna (Reporting) CIK: 0001347582 (see all company filings)

Type: 144

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38129 | Film No.: 25534143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)